The global blood glucose meters market griwth in 2026 is expanding as diabetes prevalence rises. According to Fortune Business Insights, the global blood glucose meters market size was valued at USD 20.13 billion in 2025 and is projected to grow from USD 21.82 billion in 2026 to USD 41.59 billion by 2034, exhibiting a CAGR of 8.40% during the forecast period. North America dominated the market with a 40.61% share in 2025.
Blood glucose meters are monitoring devices used to measure glucose levels and support diabetes management. The increasing demand for convenient monitoring, coupled with technological developments in wearable and non-invasive solutions, is influencing market growth. Based on technique, products are categorized as invasive and non-invasive, while by type they are divided into wearable and non-wearable devices.
The increasing diabetic population is a major factor supporting the blood glucose meters market. Fortune Business Insights highlights the growing need for accurate and reliable glucose monitoring devices as diabetes prevalence increases. Demand for non-invasive monitoring is also rising because conventional invasive monitoring can be painful. This has encouraged research and the introduction of new non-invasive devices.
The emergence of continuous glucose monitoring systems is another important growth factor. These systems use sensors to provide glucose measurements at regular intervals, offering continuous monitoring and supporting diabetes management and personalized diabetes care. Wearable continuous glucose monitors are expected to gain demand because of their ease of use and continuous monitoring capability. High investment by market players in non-invasive and wearable continuous monitoring systems, along with increasing patient awareness in emerging countries, is expected to support market expansion.
The market is also influenced by developments in software and mobile applications that enable data exchange and logging from continuous glucose meters. However, the painful nature of conventional invasive monitoring creates demand for alternative technologies and encourages innovation toward non-invasive approaches.
The competitive landscape includes major companies focusing on product development, wearable solutions, continuous glucose monitoring, and non-invasive technologies. Fortune Business Insights identifies Dexcom Inc., F. Hoffmann-La Roche Ltd., Abbott, and Medtronic among the prominent players. Companies are concentrating on strengthening their market positions through new product introductions and expanded distribution networks.
Top Companies In The Market